Incidence of hematologic malignancy and cause‐specific mortality in the Women's Health Initiative randomized controlled trial of calcium and vitamin D supplementation

Overview of attention for article published in Cancer (0008543X), June 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

news: 1 news outlet

twitter: 6 X users

Readers on

mendeley: 78 Mendeley

So far, Altmetric has seen 8 X posts from 6 X users, with an upper bound of 66,636 followers.

https://t.co/EbyRo1kBoq. مارأيك دكتورنا الغالي .. هل أبدأ وأنا في حالة نقص أم أنتظر الحسم من الدراسات !؟ @Saudi_Pharma

RT @JournalCancer: Risk of hematologic malignancy significantly lower in women who took CaD vs. placebo, according to WHI analysis https://…

Risk of hematologic malignancy significantly lower in women who took CaD vs. placebo, according to WHI analysis https://t.co/SNvKCg7iVf https://t.co/cGgbyAoeCG

Protective association b/w CaD supplementation & hematologic malignancy risk in older women found in trial analysis https://t.co/SNvKCg7iVf https://t.co/WV5lIXVMYd

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.